BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shin A, Won YJ, Jung HK, Kong HJ, Jung KW, Oh CM, Choe S, Lee J. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database. J Gastroenterol Hepatol 2018;33:1961-8. [PMID: 29802647 DOI: 10.1111/jgh.14289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Min YK, Baek S, Kang EK, Nam SJ. Characteristics of Patients With Esophageal Dysphagia Assessed by Chest X-Ray Imaging After Videofluoroscopic Swallowing Study. Ann Rehabil Med 2020;44:38-47. [PMID: 32130837 DOI: 10.5535/arm.2020.44.1.38] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Jung H. Epidemiology of and Risk Factors for Esophageal Cancer in Korea. Korean J Helicobacter Up Gastrointest Res 2019;19:145-8. [DOI: 10.7704/kjhugr.2019.19.3.145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
3 He F, Wang J, Liu L, Qin X, Wan Z, Li W, Ping Z. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015. Cancer Med 2021;10:1839-47. [PMID: 33594825 DOI: 10.1002/cam4.3647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang S, Lin S, Li N, Deng Y, Wang M, Xiang D, Xiang G, Wang S, Ye X, Zheng Y, Yao J, Zhai Z, Wu Y, Hu J, Kang H, Dai Z. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol 2020;13:146. [PMID: 33138852 DOI: 10.1186/s13045-020-00981-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Park S, Sun J, Choi Y, Oh D, Kim H, Lee T, Chi S, Lee S, Choi Y, Jung S, Ahn M, Ahn Y, Park K, Shim Y. Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study. ESMO Open 2022;7:100385. [DOI: 10.1016/j.esmoop.2022.100385] [Reference Citation Analysis]
6 Choi J, Chung H, Lee A, Kim JL, Cho SJ, Kim SG. Role of Endoscopic Ultrasound in Selecting Superficial Esophageal Cancers for Endoscopic Resection. Ann Thorac Surg 2021;111:1689-95. [PMID: 32980323 DOI: 10.1016/j.athoracsur.2020.07.029] [Reference Citation Analysis]
7 Xi Y, Dong W, Qiao L, Han K, Chen W, Wang W. Trends in incidence and mortality of esophageal cancer in Inner Mongolia, 2010-2015. Thorac Cancer 2020;11:2440-8. [PMID: 32716130 DOI: 10.1111/1759-7714.13552] [Reference Citation Analysis]
8 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
9 Kim EJ, Kim JH, Song HJ, Park SR, Kim YH, Kim HR, Kim SB. Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia Pac J Clin Oncol 2020;16:e53-62. [PMID: 31657877 DOI: 10.1111/ajco.13283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Staubitz JI, van der Sluis PC, Berlth F, Watzka F, Dette F, Läßig A, Lang H, Musholt TJ, Grimminger PP. Recurrent laryngeal nerve monitoring during totally robot-assisted Ivor Lewis esophagectomy. Langenbecks Arch Surg 2020;405:1091-9. [PMID: 32970189 DOI: 10.1007/s00423-020-01990-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lam AK. Introduction: Esophageal Squamous Cell Carcinoma-Current Status and Future Advances. Methods Mol Biol 2020;2129:1-6. [PMID: 32056165 DOI: 10.1007/978-1-0716-0377-2_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Shin A, Won YJ, Jung HK, Kong HJ, Jung KW, Oh CM, Choe S, Lee J. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database. J Gastroenterol Hepatol 2018;33:1961-8. [PMID: 29802647 DOI: 10.1111/jgh.14289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
13 Lee JE, Han K, Yoo J, Yeo Y, Cho IY, Cho B, Kwon H, Shin DW, Cho JH, Park Y. Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study. JPM 2022;12:375. [DOI: 10.3390/jpm12030375] [Reference Citation Analysis]
14 Yoon HG, Oh D, Ahn YC, Noh JM, Pyo H, Cho WK, Song YM, Park M, Hwang NY, Sun JM, Kim HK, Zo JI, Shim YM. Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer. Cancers (Basel) 2020;12:E925. [PMID: 32290037 DOI: 10.3390/cancers12040925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yoon HG, Oh D, Noh JM, Cho WK, Sun JM, Kim HK, Zo JI, Shim YM, Kim K. Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer. J Cachexia Sarcopenia Muscle 2021. [PMID: 34145771 DOI: 10.1002/jcsm.12747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Shim YM, Yun J, Im YH, Lee G, Kang D, Cho J, Kim K, Park SI, Na KJ, Kim SB, Zo JI. The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial. Dis Esophagus 2021:doab040. [PMID: 34155501 DOI: 10.1093/dote/doab040] [Reference Citation Analysis]